COVID-19 Vaccine: How Are We Progressing?

Earlier this month, we reported that Johnson & Johnson was in the midst of developing a vaccine for COVID-19. 

covid19 coronavirus, vaccine

They struck an agreement with the U.S. government for the large scale domestic manufacturing and delivery in the U.S. of 100 million doses of Janssen's SARS-CoV-2 investigational vaccine, Ad26.COV2.S, for use in the United States following approval or Emergency Use Authorization by the U.S. Food and Drug Administration (FDA).

So, where are we at now in the vaccine process? 

President Donald J. Trump is harnessing the full power of the public and private sectors to deliver a safe and effective vaccine as soon as possible.

  • The President is using all available means to ensure safe vaccines, therapeutics, and diagnostics are developed, manufactured, and distributed in unprecedented time and scale in response to COVID-19.
  • Earlier this year, President Trump launched Operation Warp Speed, a groundbreaking partnership between the Federal Government, scientific community, and private sector to develop and deliver vaccines in record time.
    • Operation Warp Speed’s goal is to produce and deliver 300 million doses of safe and effective vaccines with the initial doses available by January 2021.
  • The Administration has made large investments in multiple vaccine candidates to provide financial infrastructure for mass manufacturing, in parallel with late-stage clinical trials.
  • Operation Warp Speed is directing a colossal industrial mobilization to ensure the rapid delivery of an eventual safe vaccine.

The President’s strategy for safely expediting vaccine development is already achieving incredible results.

  • There has been promising early data from clinical trials and manufacturing is ramping up as candidates go through late-stage trials.
  • Operation Warp Speed has invested in more than five vaccines and teamed up with multiple pharmaceutical companies to safely produce as many effective vaccines as possible.
  • A number of vaccine candidates have shown promising early clinical results and are either in or starting Phase 3 clinical trials, including AstraZeneca, Moderna, and Pfizer.
  • Several vaccine candidates are using the National Institutes of Health (NIH) clinical trial network to help enroll individuals into the clinical trials.

President Trump has unleashed the power of American innovation in order to fight the invisible enemy.

  • The Trump Administration is using the whole of our Nation’s scientific genius to help combat COVID-19.
  • The Food and Drug Administration (FDA) has authorized more than 185 tests under emergency authorities, including more than 150 molecular tests and 30 antibody tests.
  • The FDA launched its Coronavirus Treatment Acceleration Program to facilitate new treatments for COVID-19 patients as quickly as possible.
  • A number of promising therapies for COVID-19, like Remdesivir, have been identified and are already in use.

Share this article:

More From LATF USA